Harpin Granted Federal Registration in Mexico

RNS Number : 2097F
Plant Health Care PLC
21 May 2013
 



 

21 May 2013

 

 

PLANT HEALTH CARE PLC

 

 

Plant Health Care's Harpin alpha beta granted federal registration in Mexico

 

Plant Health Care (AIM / CISX: PHC.L) a leading provider of novel patent protected biological products to the global agriculture markets, announces that it has received federal registration in Mexico for the use of its second generation Harpin alpha beta technology.  This proprietary Harpin technology is now approved for use on a wide range of crops in Mexico including maize, dry beans and sugar cane.

 

Paul Schmidt, CEO of Plant Health Care, commented:"We are pleased to have obtained this regulatory approval in Mexico for our Harpin alpha beta technology.  We have a strong and growing portfolio of registrations around the world and this approval marks another milestone in expanding the use of Harpin technology in new markets.  It also provides added testament to our plans for developing Harpin into a platform of powerful technologies.  We will continue to work closely with our subsidiary in Mexico and commercial partners to develop these new opportunities further."

- ENDS-

 

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets.  The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/mnemonic: PHC).

 

 

 

Further information is available at: www.planthealthcare.comor please contact:

For further information please contact:

 

Plant Health Care plc


Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

Stephen Weaver, Finance Director

Tel: +1-412-826-5488



Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden




Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden / Sophie Moate


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRANKDDBKBKDPPB
UK 100

Latest directors dealings